| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |